Liver Disease
News
Herbal medicines and supplements carry risk of hepatoxicity
Conference Coverage
All-oral, triple-acting HCV regimen cures more than 90% of cirrhotic cases
Major finding: Sustained virologic responses 12 weeks after treatment was stopped were 91.8% and 96.1%, respectively, with a 12-week and a 24-week...
News
Antiviral combo pill cures HCV in 8-12 weeks
Key clinical point: A sofosbuvir-ledipasvir combination tablet can be used in almost all genotype 1 patients with a short duration of 8-12 weeks...
News
Obeticholic acid shows promise in primary biliary cirrhosis
Major finding: The combined primary endpoint of reduction in ALP and bilirubin was achieved by 46%-47% of obeticholic acid (OCA)- and 10% of...
News
Federal government releases updated viral hepatitis action plan
From the AGA Journals
Liver histology crucial at Wilson disease diagnosis
Major finding: In Wilson disease patients, liver cirrhosis at diagnosis was the best predictor for liver transplant as well as for death (OR, 6.8...
News
Pediatric information added to label of hepatitis B antiviral entecavir
News
Outcomes linked to distance from liver transplant center
Major finding: Living more than 100 miles from a VA transplant center means that veterans in liver failure are less likely to survive to...
News
Patients with both HIV and HCV have higher hepatic decompensation rates, despite antiretrovirals
Major finding: About 7.4% of coinfected patients and 4.8% of monoinfected patients had hepatic decompensation at 10 years (hazard ratio, 1.56; 95...
News
No postop phosphorus dip worrisome for hepatectomy patients
Major finding: A posthepatectomy phosphorus of more than 2.4 mg/dL increased the risk of hepatic insufficiency by 78% and nearly tripled the risk...